SCHEMBL24201220

SCHEMBL24201220

C/C(C=O)=C\c1cc(F)c(Oc2ccc(SNc3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c3)cc2)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SLC9A3 P48764 13/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19593827 0.75 SLC9A3 (0.41) SLC9A3
SCHEMBL23469883 0.72 SLC9A3 (0.36) SLC9A3
SCHEMBL20404475 0.72 SLC9A3 (0.36) SLC9A3
SCHEMBL19593907 0.69 SLC9A3 (0.36) SLC9A3
SCHEMBL24201173 0.68 LTA4H (0.33) SLC9A3
SCHEMBL19593895 0.68 SLC9A3 (0.36) SLC9A3
SCHEMBL23469959 0.67 SLC9A3 (0.51) SLC9A3
SCHEMBL13467244 0.67 SLC9A3 (0.64) SLC9A3
SCHEMBL19593418 0.67 SLC9A3 (0.53) SLC9A3
SCHEMBL24201229 0.66 SLC9A3 (0.48) SLC9A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939964-A1 COMBINATIONS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS Ardelyx, Inc. (US) 2022-01-19 — — EP disclosed
Send feedback